The MYCN-driven cluster C included not only MYCN-amplified retinoblastomas, but two samples with high MYCN target expression that lacked MYCN amplifications, suggesting alternative ways of activating MYCN-driven tumor progression in retinoblastoma. This evidence concerns the gene MYCN and retinoblastoma.